Dashboard
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 29.01%
- Healthy long term growth as Net Sales has grown by an annual rate of 21.86% and Operating profit at 30.30%
- Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 52.45
2
With ROE of 27.2, it has a attractive valuation with a 3.7 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
PKR 53,905 Million (Large Cap)
18.00
NA
3.93%
-0.18
26.44%
4.36
Revenue and Profits:
Net Sales:
7,026 Million
(Quarterly Results - Mar 2025)
Net Profit:
955 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.8%
0%
7.8%
6 Months
0.65%
0%
0.65%
1 Year
39.35%
0%
39.35%
2 Years
141.94%
0%
141.94%
3 Years
133.19%
0%
133.19%
4 Years
115.22%
0%
115.22%
5 Years
172.95%
0%
172.95%
Highnoon Laboratories Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
20.74%
EBIT Growth (5y)
26.62%
EBIT to Interest (avg)
52.45
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
1.95
Tax Ratio
32.94%
Dividend Payout Ratio
62.54%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
60.12%
ROE (avg)
29.01%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
5.28
EV to EBIT
9.77
EV to EBITDA
9.17
EV to Capital Employed
6.42
EV to Sales
2.25
PEG Ratio
0.88
Dividend Yield
3.51%
ROCE (Latest)
65.79%
ROE (Latest)
29.99%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
Mar'25
Dec'24
Change(%)
Net Sales
7,025.90
6,305.60
11.42%
Operating Profit (PBDIT) excl Other Income
1,540.30
2,059.20
-25.20%
Interest
27.80
230.00
-87.91%
Exceptional Items
0.00
157.80
-100.00%
Consolidate Net Profit
954.60
992.70
-3.84%
Operating Profit Margin (Excl OI)
207.30%
313.40%
-10.61%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2025 is 11.42% vs 0.32% in Dec 2024
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2025 is -3.84% vs 25.79% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
24,629.50
19,766.30
24.60%
Operating Profit (PBDIT) excl Other Income
5,390.90
3,704.70
45.52%
Interest
407.00
153.00
166.01%
Exceptional Items
157.80
32.00
393.12%
Consolidate Net Profit
3,388.50
2,447.70
38.44%
Operating Profit Margin (Excl OI)
204.40%
173.60%
3.08%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 24.60% vs 24.98% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 38.44% vs -1.01% in Dec 2023
About Highnoon Laboratories Ltd. 
Highnoon Laboratories Ltd.
Pharmaceuticals & Biotechnology
Highnoon Laboratories Limited is a Pakistan-based pharmaceutical company. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products. The Company offers products for various therapeutic areas, such as alimentary tract and metabolism, cardiovascular and respiratory products. The Company's product brands for alimentary tract and metabolism include Tres Orix Forte, Ulsanic, Skilax and Tagipmet. The Company's cardiovascular portfolio includes Misar brand, which is an angiotensin receptor blocker (ARB) used in the management of hypertension. Its products include AIRTAL (Aceclofenac), which has non-steroidal, anti-inflammatory and analgesic properties; ARIA (ketotifen), a non-bronchodilator antiasthamatic drug; ARTECXCIN, which acts as a blood schizotocide, and artrodar (diacerein), used for the treatment of inflammation and rheumatism. Its other products include Asthavent, AXESOME, Bezisox and Betatec.
Company Coordinates 
Company Details
17.5 Kilometer Multan Road , LAHORE None : 53700
Registrar Details






